Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pneumonia, Viral"" wg kryterium: Temat


Tytuł :
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).
Autorzy :
O'Reilly GM; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; National Trauma Research Institute, Alfred Health, Melbourne, Victoria, Australia.
Mitchell RD; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Mitra B; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; National Trauma Research Institute, Alfred Health, Melbourne, Victoria, Australia.
Akhlaghi H; Emergency Department, St Vincent's Hospital, Melbourne, Victoria, Australia.; Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Tran V; Emergency Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.; Tasmanian School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Furyk JS; Emergency Department, Barwon Health, Geelong, Victoria, Australia.; School of Medicine, Deakin University, Geelong, Victoria, Australia.
Buntine P; Emergency Department, Eastern Health, Melbourne, Victoria, Australia.; Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
Wong A; Emergency Department, Austin Hospital, Melbourne, Victoria, Australia.; Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.; School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
Gangathimmaiah V; Emergency Department, Townsville University Hospital, Townsville, Queensland, Australia.
Knott J; Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.; Emergency Department, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Raos M; Emergency Department, Sutherland Hospital, Sydney, New South Wales, Australia.
Chatterton E; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Nursing and Midwifery, La Trobe University, Melbourne, Victoria, Australia.; School of Nursing and Midwifery, Deakin University, Melbourne, Victoria, Australia.
Sevior C; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.
Parker S; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; Department of Anaesthetics, Peter MacCallum Hospital, Melbourne, Victoria, Australia.
Baker S; Emergency Department, St Vincent's Hospital, Melbourne, Victoria, Australia.
Loughman A; Emergency Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.; Ambulance Tasmania, Hobart, Tasmania, Australia.
Lowry N; Emergency Department, Barwon Health, Geelong, Victoria, Australia.
Freeman D; Emergency Department, Eastern Health, Melbourne, Victoria, Australia.
Sri-Ganeshan M; Emergency Department, Austin Hospital, Melbourne, Victoria, Australia.
Chapman N; Emergency Department, Townsville University Hospital, Townsville, Queensland, Australia.
Siu S; Emergency Department, Sutherland Hospital, Sydney, New South Wales, Australia.
Noonan MP; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; National Trauma Research Institute, Alfred Health, Melbourne, Victoria, Australia.; Trauma Service, Alfred Health, Melbourne, Victoria, Australia.
Smit V; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; National Trauma Research Institute, Alfred Health, Melbourne, Victoria, Australia.
Cameron PA; Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Corporate Authors :
COVED Project Team
Źródło :
Emergency medicine Australasia : EMA [Emerg Med Australas] 2021 Apr; Vol. 33 (2), pp. 331-342. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Testing*
Emergency Service, Hospital*
COVID-19/*diagnosis
COVID-19/*epidemiology
Pneumonia, Viral/*diagnosis
Pneumonia, Viral/*epidemiology
Australia/epidemiology ; COVID-19/mortality ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Patient Isolation ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; Prospective Studies ; Respiration, Artificial ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
Autorzy :
Fertitta L; Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Welfringer-Morin A; Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Ouedrani A; Institut Necker-Enfants Malades, Université de Paris, Paris, France.; Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Polivka L; Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Chhun S; Institut Necker-Enfants Malades, Université de Paris, Paris, France.; Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Chatenoud L; Institut Necker-Enfants Malades, Université de Paris, Paris, France.; Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Fourgeaud J; Laboratory of Virology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Hadj-Rabia S; Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; INSERM U1163, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Temmam S; Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.
Eloit M; Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.
Sermet-Gaudelus I; Department of Pneumology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center Rare Diseases: cystic fibrosis, Paris, France.; INSERM U1151, Institut Necker - Enfants Malades, Université de Paris, Paris, France.
Bodemer C; Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; INSERM U1163, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Mar; Vol. 35 (3), pp. e164-e167. Date of Electronic Publication: 2020 Dec 21.
Typ publikacji :
Letter
MeSH Terms :
COVID-19/*complications
COVID-19/*immunology
Chilblains/*immunology
Chilblains/*virology
Pneumonia, Viral/*complications
Pneumonia, Viral/*immunology
Adolescent ; COVID-19/diagnosis ; Child ; Child, Preschool ; Female ; France ; Humans ; Infant ; Male ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/virology ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London.
Autorzy :
Vaid N; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Ardissino M; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Reed TAN; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Goodall J; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Utting P; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Miscampbell M; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Condurache D; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Cohen DL; From the, London North West Healthcare NHS Trust, Northwick Park Hospital, London, UK.
Pokaż więcej
Źródło :
Journal of internal medicine [J Intern Med] 2021 Mar; Vol. 289 (3), pp. 385-394. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article
MeSH Terms :
Hospitalization*
Immunocompromised Host*
COVID-19/*epidemiology
COVID-19/*immunology
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*immunology
Aged ; Aged, 80 and over ; COVID-19/mortality ; Continuous Positive Airway Pressure ; Female ; Hospital Mortality ; Humans ; Immunosuppressive Agents/administration & dosage ; London/epidemiology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging.
Autorzy :
Bello-Chavolla OY; Division of Research, Instituto Nacional de Geriatría, Mexico City, Mexico.; Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
González-Díaz A; Universidad Nacional Autónoma de México, Mexico City, Mexico.
Antonio-Villa NE; Division of Research, Instituto Nacional de Geriatría, Mexico City, Mexico.; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Fermín-Martínez CA; Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Márquez-Salinas A; Division of Research, Instituto Nacional de Geriatría, Mexico City, Mexico.; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Vargas-Vázquez A; Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Bahena-López JP; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
García-Peña C; Division of Research, Instituto Nacional de Geriatría, Mexico City, Mexico.
Aguilar-Salinas CA; Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Department of Endocrinolgy and Metabolism. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Nuevo León, Mexico.
Gutiérrez-Robledo LM; Division of Research, Instituto Nacional de Geriatría, Mexico City, Mexico.
Pokaż więcej
Źródło :
The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2021 Feb 25; Vol. 76 (3), pp. e52-e59.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Status Disparities*
COVID-19/*mortality
COVID-19/*physiopathology
Pneumonia, Viral/*mortality
Pneumonia, Viral/*physiopathology
Age Factors ; Aged ; Aged, 80 and over ; Aging ; COVID-19/epidemiology ; Comorbidity ; Disease Susceptibility ; Female ; Humans ; Incidence ; Male ; Mexico/epidemiology ; Middle Aged ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Community continuous positive airway pressure therapy and non-invasive ventilation use during the COVID-19 pandemic.
Autorzy :
Chiang KY; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Ip MSM; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Lui MMS; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Pokaż więcej
Źródło :
Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2021 Feb; Vol. 27 (1), pp. 64-66. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*prevention & control
COVID-19/*transmission
Continuous Positive Airway Pressure/*methods
Noninvasive Ventilation/*methods
Pneumonia, Viral/*prevention & control
Pneumonia, Viral/*transmission
Sleep Apnea, Obstructive/*therapy
COVID-19/epidemiology ; Hong Kong/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Salvage Lobectomy to Treat Necrotizing SARS-CoV-2 Pneumonia Complicated by a Bronchopleural Fistula.
Autorzy :
Peeters K; Department of Thoracovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium. Electronic address: .
Mesotten D; Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Willaert X; Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Deraedt K; Department of Pathology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Nauwelaers S; Department of Thoracovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.
Lauwers G; Department of Thoracovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2021 Apr; Vol. 111 (4), pp. e241-e243. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Case Reports
MeSH Terms :
Bronchial Fistula/*surgery
COVID-19/*complications
Lung/*diagnostic imaging
Pleural Diseases/*surgery
Pneumonectomy/*methods
Pneumonia, Viral/*complications
Adult ; Bronchial Fistula/diagnosis ; Bronchial Fistula/etiology ; COVID-19/diagnosis ; COVID-19/epidemiology ; Female ; Humans ; Lung/surgery ; Pleural Diseases/diagnosis ; Pleural Diseases/etiology ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/surgery ; Tomography, X-Ray Computed
Raport
Tytuł :
Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
Autorzy :
McGuire SS; Department of Emergency Medicine, Mayo Clinic, Rochester, MinnesotaUSA.; Division of Prehospital Care, Mayo Clinic, Rochester, MinnesotaUSA.
Klassen AB; Department of Emergency Medicine, Mayo Clinic, Rochester, MinnesotaUSA.; Division of Prehospital Care, Mayo Clinic, Rochester, MinnesotaUSA.
Heywood J; Mayo Clinic Labs, Mayo Clinic, Rochester, MinnesotaUSA.
Sztajnkrycer MD; Department of Emergency Medicine, Mayo Clinic, Rochester, MinnesotaUSA.; Division of Prehospital Care, Mayo Clinic, Rochester, MinnesotaUSA.
Pokaż więcej
Źródło :
Prehospital and disaster medicine [Prehosp Disaster Med] 2021 Apr; Vol. 36 (2), pp. 131-134. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article
MeSH Terms :
Emergency Responders*
Antibodies, Viral/*blood
COVID-19/*blood
COVID-19/*epidemiology
Immunoglobulin G/*blood
Pneumonia, Viral/*blood
Pneumonia, Viral/*epidemiology
Adult ; COVID-19 Testing ; Female ; Humans ; Male ; Minnesota/epidemiology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia.
Autorzy :
Morales-Nebreda L; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Helmin KA; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Torres Acosta MA; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Markov NS; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Hu JY; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Joudi AM; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Piseaux-Aillon R; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Abdala-Valencia H; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Politanska Y; Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Singer BD; Department of Medicine, Division of Pulmonary and Critical Care Medicine.; Department of Biochemistry and Molecular Genetics, and.; Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pokaż więcej
Źródło :
JCI insight [JCI Insight] 2021 Mar 22; Vol. 6 (6). Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Influenza A virus*
SARS-CoV-2*
Aging/*physiology
Influenza, Human/*pathology
Lung/*pathology
Pneumonia, Viral/*pathology
T-Lymphocytes, Regulatory/*pathology
Age Factors ; Aging/metabolism ; Animals ; COVID-19/complications ; COVID-19/metabolism ; COVID-19/pathology ; COVID-19/virology ; Humans ; Influenza, Human/complications ; Influenza, Human/metabolism ; Influenza, Human/virology ; Lung/metabolism ; Mice, Inbred C57BL ; Pneumonia, Viral/etiology ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/virology ; T-Lymphocytes, Regulatory/metabolism
Czasopismo naukowe
Tytuł :
Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Autorzy :
Lahmer T; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Kriescher S; Klinik und Poliklinik für Aneasthesiologie und Intensivmedizin, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Herner A; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Rothe K; Institut für Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Munich, Germany.
Spinner CD; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Schneider J; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Mayer U; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Neuenhahn M; Institut für Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Munich, Germany.
Hoffmann D; Institut für Virologie, Technische Universität München, Munich, Germany.
Geisler F; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Heim M; Klinik und Poliklinik für Aneasthesiologie und Intensivmedizin, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Schneider G; Klinik und Poliklinik für Aneasthesiologie und Intensivmedizin, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Schmid RM; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Huber W; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Rasch S; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Mar 17; Vol. 16 (3), pp. e0238825. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*complications
Invasive Pulmonary Aspergillosis/*etiology
Pneumonia, Viral/*complications
Adult ; Aged ; Aged, 80 and over ; Bronchoalveolar Lavage Fluid/microbiology ; Bronchoalveolar Lavage Fluid/virology ; COVID-19/microbiology ; COVID-19/virology ; Critical Illness ; Female ; Humans ; Intensive Care Units ; Invasive Pulmonary Aspergillosis/microbiology ; Invasive Pulmonary Aspergillosis/virology ; Male ; Mannans/metabolism ; Middle Aged ; Pneumonia, Viral/microbiology ; Pneumonia, Viral/virology ; Prospective Studies ; Respiration, Artificial/methods ; SARS-CoV-2/pathogenicity ; Superinfection/etiology ; Superinfection/microbiology
Czasopismo naukowe
Tytuł :
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
Autorzy :
Gokhale Y; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India. .
Mehta R; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Kulkarni U; Christian Medical College, Vellore, Tamil Nadu, India.
Karnik N; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Gokhale S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Sundar U; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Chavan S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Kor A; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Thakur S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Trivedi T; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Kumar N; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Baveja S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Wadal A; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Kolte S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Deolankar A; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Pednekar S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Kalekar L; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Padiyar R; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Londhe C; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Darole P; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Pol S; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Gokhe SB; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Padwal N; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Pandey D; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Yadav D; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Joshi A; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Badgujar H; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Trivedi M; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Shah P; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Bhavsar P; Lokmanya Tilak Municipal Medical College, Sion Mumbai, 400022, India.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Mar 05; Vol. 21 (1), pp. 241. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19*/physiopathology
COVID-19*/therapy
Cytokine Release Syndrome*/etiology
Cytokine Release Syndrome*/immunology
Cytokine Release Syndrome*/therapy
Hypoxia*/etiology
Hypoxia*/therapy
Pneumonia, Viral*/blood
Pneumonia, Viral*/etiology
Pneumonia, Viral*/mortality
Pneumonia, Viral*/therapy
Antibodies, Monoclonal, Humanized/*administration & dosage
Interleukin-6/*antagonists & inhibitors
Compassionate Use Trials/statistics & numerical data ; Female ; Humans ; India/epidemiology ; Interleukin-6/immunology ; Male ; Middle Aged ; Respiration, Artificial/methods ; Retrospective Studies ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The semantic of a pandemic: Are cardiovascular patients dying "with" or "from" COVID-19? Reflections from a case report.
Autorzy :
Mapelli M; Centro Cardiologico Monzino IRCCS.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.
Mantegazza V; Centro Cardiologico Monzino IRCCS.
Agostoni P; Centro Cardiologico Monzino IRCCS.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Mar 05; Vol. 100 (9), pp. e25072.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19*/diagnosis
COVID-19*/mortality
COVID-19*/physiopathology
Coronary Artery Disease*/epidemiology
Coronary Artery Disease*/physiopathology
Coronary Artery Disease*/therapy
Hypertension*/epidemiology
Hypertension*/physiopathology
Hypertension*/therapy
Pneumonia, Viral*/blood
Pneumonia, Viral*/diagnostic imaging
Pneumonia, Viral*/physiopathology
Pneumonia, Viral*/therapy
Patient Care Management/*methods
Aged ; Blood Gas Analysis/methods ; COVID-19 Nucleic Acid Testing/methods ; Clinical Deterioration ; Fatal Outcome ; Humans ; Male ; Risk Assessment ; SARS-CoV-2/isolation & purification ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
[The advanced practice nurse in post-COViD-19 respiratory follow up].
Autorzy :
Blanchard PY; Groupe hospitalier AP-HP Sorbonne Université, département médico-universitaire Approches, hôpital Tenon, AP-HP, 4 rue de la Chine, 75020 Paris, France; Groupe hospitalier AP-HP Sorbonne Université, département médico-universitaire Approches, hôpital de la Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013 Paris, France. Electronic address: .
Ruppert AM; Groupe hospitalier AP-HP Sorbonne Université, département médico-universitaire Approches, hôpital Tenon, AP-HP, 4 rue de la Chine, 75020 Paris, France.
Faure M; Groupe hospitalier AP-HP Sorbonne Université, département médico-universitaire Approches, hôpital de la Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013 Paris, France.
Nion N; Groupe hospitalier AP-HP Sorbonne Université, département médico-universitaire Approches, hôpital de la Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013 Paris, France.
Pokaż więcej
Transliterated Title :
L'IPA dans le suivi respiratoire post-Covid-19.
Źródło :
Soins; la revue de reference infirmiere [Soins] 2021 Mar; Vol. 66 (853), pp. 32-34.
Typ publikacji :
Journal Article
MeSH Terms :
Advanced Practice Nursing*
COVID-19*/complications
Pneumonia, Viral*/nursing
Pneumonia, Viral*/virology
Humans ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Lower Respiratory Tract Myeloid Cells Harbor SARS-Cov-2 and Display an Inflammatory Phenotype.
Autorzy :
Bain WG; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA; Staff Physician, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA.
Peñaloza HF; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
Ladinsky MS; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA.
van der Geest R; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
Sullivan M; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
Ross M; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
Kitsios GD; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
Methé BA; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
McVerry BJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
Morris A; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA.
Watson AM; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
Watkins SC; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
St Croix CM; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
Stolz DB; Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA.
Bjorkman PJ; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA.
Lee JS; Division of Pulmonary, Allergy, and Critical Care Medicine, Acute Lung Injury Center of Excellence, Pittsburgh, PA. Electronic address: .
Pokaż więcej
Źródło :
Chest [Chest] 2021 Mar; Vol. 159 (3), pp. 963-966. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/immunology
COVID-19*/physiopathology
COVID-19*/therapy
COVID-19*/virology
Lung*/immunology
Lung*/pathology
Lung*/virology
Pneumonia, Viral*/immunology
Pneumonia, Viral*/virology
SARS-CoV-2*/isolation & purification
SARS-CoV-2*/physiology
Virus Replication*
Myeloid Cells/*pathology
Antibodies, Viral/analysis ; Coronavirus Nucleocapsid Proteins/immunology ; Electron Microscope Tomography ; Female ; Humans ; Immunity, Mucosal ; Male ; Microscopy, Electron ; Middle Aged ; Neutrophils/pathology ; Phosphoproteins/immunology ; Respiration, Artificial/methods ; Respiratory Mucosa/immunology ; Respiratory Mucosa/virology
Czasopismo naukowe
Tytuł :
COVID-19 and the role of inequality in French regional departments.
Autorzy :
Ginsburgh V; ECARES, Université Libre de Bruxelles and CORE, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Magerman G; ECARES, Université Libre de Bruxelles and I3h, Université Libre de Bruxelles, Brussels, Belgium. .
Natali I; ECARES, Université Libre de Bruxelles and I3h, Université Libre de Bruxelles, Brussels, Belgium.
Pokaż więcej
Źródło :
The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2021 Mar; Vol. 22 (2), pp. 311-327. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article
MeSH Terms :
Health Status Disparities*
COVID-19/*epidemiology
Income/*statistics & numerical data
Pneumonia, Viral/*epidemiology
COVID-19/mortality ; France/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Vulnerable Populations
Czasopismo naukowe
Tytuł :
Prone positioning in patients with acute respiratory distress syndrome, translating research and implementing practice change from bench to bedside in the era of coronavirus disease 2019.
Autorzy :
Apte Y; Intensive Care Unit, Redcliffe Hospital, Australia; Intensive Care Unit, Caboolture Hospital, Australia; University of Queensland, Australia. Electronic address: .
Jacobs K; Intensive Care Unit, Redcliffe Hospital, Australia; University of Queensland, Australia.
Shewdin S; Intensive Care Unit, Redcliffe Hospital, Australia; Intensive Care Unit, Caboolture Hospital, Australia; University of Queensland, Australia.
Murray A; Intensive Care Unit, Redcliffe Hospital, Australia; Intensive Care Unit, Caboolture Hospital, Australia; University of Queensland, Australia.
Tung L; Intensive Care Unit, Redcliffe Hospital, Australia; Intensive Care Unit, Caboolture Hospital, Australia.
Ramanan M; Intensive Care Unit, Redcliffe Hospital, Australia; Intensive Care Unit, Caboolture Hospital, Australia; University of Queensland, Australia; Intensive Care Unit, Prince Charles Hospital, Australia; The George Institute for Global Health, Australia; University of New South Wales, Australia.
Massey D; Southern Cross University, Queensland, Australia.
Pokaż więcej
Źródło :
Australian critical care : official journal of the Confederation of Australian Critical Care Nurses [Aust Crit Care] 2021 Mar; Vol. 34 (2), pp. 176-181. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Prone Position*
COVID-19/*therapy
Pneumonia, Viral/*therapy
Respiratory Distress Syndrome/*therapy
Adult ; Aged ; COVID-19/epidemiology ; Female ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Patient Selection ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Queensland/epidemiology ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs.
Autorzy :
Bartoli A; Division of Internal Medicine and Metabolism, Department of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy. .
Gabrielli F; Division of Internal Medicine and Metabolism, Department of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Alicandro T; Division of Internal Medicine and Metabolism, Department of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Nascimbeni F; Division of Internal Medicine and Metabolism, Department of Internal Medicine, University Hospital of Modena, Modena, Italy.
Andreone P; Division of Internal Medicine and Metabolism, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Pokaż więcej
Źródło :
Internal and emergency medicine [Intern Emerg Med] 2021 Mar; Vol. 16 (2), pp. 281-308. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Heparin, Low-Molecular-Weight/*therapeutic use
Immunologic Factors/*therapeutic use
Pneumonia, Viral/*drug therapy
Steroids/*therapeutic use
COVID-19/epidemiology ; Drugs, Investigational/therapeutic use ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Management of SARS-CoV-2 pneumonia.
Autorzy :
Sagnelli C; Section of Infectious Diseases, Department of Mental health and Public Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Celia B; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Monari C; Section of Infectious Diseases, Department of Mental health and Public Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Cirillo S; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
De Angelis G; Section of Infectious Diseases, Department of Mental health and Public Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Bianco A; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Coppola N; Section of Infectious Diseases, Department of Mental health and Public Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Mar; Vol. 93 (3), pp. 1276-1287. Date of Electronic Publication: 2020 Oct 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Pneumonia, Viral/*drug therapy
Acute Lung Injury/drug therapy ; Acute Lung Injury/pathology ; Acute Lung Injury/physiopathology ; COVID-19/pathology ; COVID-19/physiopathology ; Disease Management ; Humans ; Lung/diagnostic imaging ; Lung/pathology ; Pneumonia, Viral/pathology ; Pneumonia, Viral/physiopathology
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
COVID-19 screening center models in South Korea.
Autorzy :
Kim JE; Department of Health Administration, Yonsei University Graduate School, Wonju, Republic of Korea.
Lee JH; Department of Health Administration, Yonsei University Graduate School, Wonju, Republic of Korea.
Lee H; Department of Health Administration, Yonsei University Graduate School, Wonju, Republic of Korea.
Moon SJ; Department of Health Administration, Yonsei University Graduate School, Wonju, Republic of Korea.
Nam EW; Yonsei Global Health Center, Yonsei University, Wonju, Republic of Korea. .; Department of Health Administration, Yonsei University, Changjo Hall 412, Yonseidae-gil 1, Wonju, 26493, Republic of Korea. .
Pokaż więcej
Źródło :
Journal of public health policy [J Public Health Policy] 2021 Mar; Vol. 42 (1), pp. 15-26. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Testing/*methods
Communicable Disease Control/*methods
Mass Screening/*methods
Pneumonia, Viral/*prevention & control
COVID-19/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Republic of Korea/epidemiology ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort.
Autorzy :
Bajaj JS; Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia, USA .; Department of Medicine, Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Central Virginia Health Care System, Richmond, Virginia, USA.
Garcia-Tsao G; Department of Medicine, Internal Medicine, Yale University, New Haven, Connecticut, USA.
Biggins SW; University of Washington, Seattle, Washington, USA.
Kamath PS; Department of Medicine, Gastroenterology and Hepatology, Mayo Medical School, Rochester, Minnesota, USA.
Wong F; Toronto General Hospital, Toronto, Ontario, Canada.
McGeorge S; Department of Medicine, Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Central Virginia Health Care System, Richmond, Virginia, USA.
Shaw J; Department of Medicine, Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Central Virginia Health Care System, Richmond, Virginia, USA.
Pearson M; University of Washington, Seattle, Washington, USA.
Chew M; Department of Medicine, Internal Medicine, Yale University, New Haven, Connecticut, USA.
Fagan A; Department of Medicine, Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Central Virginia Health Care System, Richmond, Virginia, USA.
de la Rosa Rodriguez R; Department of Medicine, Internal Medicine, Yale University, New Haven, Connecticut, USA.
Worthington J; Department of Medicine, Gastroenterology and Hepatology, Mayo Medical School, Rochester, Minnesota, USA.
Olofson A; Department of Medicine, Gastroenterology and Hepatology, Mayo Medical School, Rochester, Minnesota, USA.
Weir V; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Trisolini C; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dwyer S; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Reddy KR; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło :
Gut [Gut] 2021 Mar; Vol. 70 (3), pp. 531-536. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
COVID-19/*mortality
Liver Cirrhosis/*mortality
Pneumonia, Viral/*mortality
COVID-19/complications ; Female ; Humans ; Inpatients ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Pneumonia, Viral/complications ; Pneumonia, Viral/virology ; Risk ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
Autorzy :
Schäfer A; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Muecksch F; Laboratory of Retrovirology, The Rockefeller University, New York, NY.
Lorenzi JCC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Leist SR; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Cipolla M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Bournazos S; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
Schmidt F; Laboratory of Retrovirology, The Rockefeller University, New York, NY.
Maison RM; Laboratory of Animal Reproduction and Biotechnology, Colorado State University, Fort Collins, CO.
Gazumyan A; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Martinez DR; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Baric RS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Robbiani DF; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Hatziioannou T; Laboratory of Retrovirology, The Rockefeller University, New York, NY.
Ravetch JV; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
Bieniasz PD; Laboratory of Retrovirology, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY.
Bowen RA; Laboratory of Animal Reproduction and Biotechnology, Colorado State University, Fort Collins, CO.
Nussenzweig MC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY.
Sheahan TP; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2021 Mar 01; Vol. 218 (3).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antibodies, Monoclonal, Murine-Derived*/immunology
Antibodies, Monoclonal, Murine-Derived*/pharmacology
Antibodies, Neutralizing*/immunology
Antibodies, Neutralizing*/pharmacology
Antibodies, Viral*/immunology
Antibodies, Viral*/pharmacology
Coronavirus Infections*/immunology
Coronavirus Infections*/therapy
Pandemics*
Pneumonia, Viral*/immunology
Pneumonia, Viral*/therapy
Betacoronavirus/*immunology
Animals ; COVID-19 ; Cell Line ; Female ; Humans ; Mesocricetus ; Mice ; Mice, Inbred BALB C ; SARS-CoV-2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies